Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Delivery-and-expression-of-a-hybrid-surface-protein-on-the-surface-of-gram-positive-bacteria

 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy
The invention claimed is: 1. A method for treating a cancer patient who is undergoing or has ...


 Method of treating cardiovascular diseases
OF PREFERRED EMBODIMENTS As examples of the diseases which the method according to the invention ...


 Rapid production of autologous tumor vaccines
In accordance with the present invention an autologous vaccine to tumor cells is produced by ...


 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
OF THE INVENTION In accordance with the invention novel therapeutic use is provided for certain ...


 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
OF THE INVENTION Inhibition of Engineered Kinases FIG. 9 shows a schematic representation of an ...


 Method for the production of bacterial toxins
The present invention is based upon the discovery that bacterial toxin expression inhibitors ...


 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
OF PREFERRED EMBODIMENTS In its preferred embodiments, this invention involves preparation and ...


 Modified protein kinase A-specific oligonucleotides and methods of their use
The present invention relates to modified oligonucleotides useful for studies of gene expression ...


 Peptides and nucleic acid sequences related to the Epstein Barr virus
OF THE INVENTION The term "peptide" as used herein refers to a molecular chain of amino acids with ...


 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
The present invention provides a method of optimizing therapeutic efficacy of 6-mercaptopurine drug ...


 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria

Details
Inventors: Fischetti, Vincent A.; Pozzi, Gianni; Schneewind, Olaf;
Assignee: The Rockefeller University (New York, NY)
Primary Examiner: Minnifield; Nita
Assistant Examiner:
Attorney, Agent or Firm: Burns, Doane, Swecker & Mathis, LLP

Process is described for the delivery and expression of hybrid surface proteins to the surface of bacteria. The transformed bacteria are useful as vaccines, for the delivery of other active peptides to animal hosts, as diagnostic reagents and for other purposes.

DETAILED DESCRIPTION What is claimed is: 1.
An isolated and purified DNA molecule encoding a hybrid protein, said hybrid protein comprising a heterologous polypeptide attached to the N-terminal end of the anchor region of a surface antigen of gram positive bacteria, wherein said DNA molecule, when expressed by gram positive bacteria, is expressed as a surface protein, with the anchor region bound to the bacteria and the heterologous peptide exposed on the surface of the bacteria.
2.
A plasmid comprising the isolated and purified DNA molecule according to claim 1.
3.
A chromosome comprising the isolated and purified DNA molecule according to claim 1.
4.
The plasmid pVMB20, deposited at the American Type Culture Collection under the accession number PTA433.
5.
The plasmid pVMB21.
6.
The S.
gordonii strain GP246.
7.
An isolated and purified non-pathogenic gram positive bacteria which expresses a hybrid surface protein comprising an anchor sequence which is attached to the bacteria fused to a heterologous polypeptide, wherein said anchor sequence is the anchor sequence of a surface antigen of a gram positive bacteria.
8.
The isolated and purified non-pathogenic gram-positive bacteria according to claim 7 wherein the heterologous polypeptide is an enzyme.
9.
The isolated and purified non-pathogenic gram-positive bacteria according to claim 7 wherein the heterologous polypeptide is a surface antigen of a mammalian tumor cell.
10.
The isolated and purified non-pathogenic gram-positive bacteria according to claim 7 wherein the heterologous polypeptide is a surface antigen of male sperm.
11.
The isolated and purified gram-positive bacteria according to claim 7 wherein the heterologous polypeptide is an allergen.
12.
The isolated and purified non-pathogenic gram-positive bacteria according to claim 7 wherein the heterologous polypeptide is selected from the group consisting of an antigenic determinant of a surface antigen of a bacteria, an antigenic determinant of a surface antigen of a virus, an antigenic determinant of a surface antigen of a parasite, and an antigenic determinant of a surface antigen of a fungus



Related patents
  Lentiviral packaging constructs
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional techniques of cell biology, molecular biology, cell culture,...
  Method for measuring no synthase activity
OF THE INVENTION In the context of the present invention the following definitions apply: Incubation: the introduction and leaving of a biological object, such as an ...
  Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
In one aspect, the present invention pertains to the discovery herein that Wnt polypeptides ("Wnts"), such as Wnt-5a, play a role in hematopoiesis. In another aspect, ...
  Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
The invention relates to a composition for delivery of a virus vector to an animal cell. The composition comprises a hydrogel precursor mixture having the virus vector ...
  Particle delivery techniques
OF THE PREFERRED EMBODIMENTS The practice of the present invention will employ, unless otherwise indicated, conventional methods of molecular biology and recombinant DNA...
  Tissue anchor system
The invention claimed is: 1. An adjustable tissue anchor comprising: a. an anchor body having a first and second open end with an interior chamber running between said ...
  Ribozyme mediated inactivation of the androgen receptor
The present invention describes inactivation of AR gene expression by engineering hammerhead ribozymes to cleave specific sites in AR mRNA. The present in vitro studies ...
  Thyrotropin-releasing hormone analogues and their therapeutic applications
The present invention pertains to novel TRH analogues, compositions, and methods for the controlled administration of novel TRH analogues to mammals. The present ...
  Probiotics in primary prevention of atopic diseases
What is claimed is: 1. A method for prevention of atopic diseases selected from the group consisting of atopic eczema, allergic rhinitis and asthma in an infant at high ...
  Humanin-like peptide and use thereof
The invention claimed is: 1. A polypeptide comprising an amino acid sequence as shown in SEQ ID NO: 4, or an amide, ester or salt thereof. 2. The polypeptide according ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved